Newly-Diagnosed Diabetes and Sustained Hyperglycemia are Associated with Poorer Outcomes in COVID-19 Inpatients Without Pre-Existing Diabetes.

Lijin LinZe ChenTing DingHui LiuFeng ZhouXuewei HuangXingyuan ZhangWeifang LiuBing-Hong ZhangYufeng YuanPeng ZhangXiao-Jing ZhangZhi-Gang SheJingjing CaiWenping ChenHongliang Li

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2021)

Our study reinforces the clinical message that NDD is strongly associated with poor outcomes in COVID-19 patients. Furthermore, resolved hyperglycemia in the later phase of the disease and the use of hypoglycemic agents were associated with improved prognosis in patients with NDD.

Keyphrases

sars cov
newly diagnosed
glycemic control
type diabetes
cardiovascular disease
metabolic syndrome
weight loss
skeletal muscle